Effects of flow-dose enzyme replacement therapy in bones in Gaucher disease patients with severe skeletal involvement

Blood Cells, Molecules, and Diseases

Volumn 22, Issue 2, 1996, Pages 104-111

  Elstein, Deborah ^a   Hadas Halpern, Irith ^a   Itzchaki, Menachem ^a   Lahad, Amnon ^a   Abrahamov, Ayala ^a   Zimran, Ari ^a  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

alglucerase; avascular necrosis; Gaucher disease; imiglucerase

Indexed keywords

ALGLUCERASE; IMIGLUCERASE; GLUCOSYLCERAMIDASE;

ADULT; ARTICLE; BONE DISEASE; CLINICAL ARTICLE; ENZYME REPLACEMENT; FEMALE; GAUCHER DISEASE; HUMAN; MALE; PRIORITY JOURNAL; SPLEEN; ADOLESCENT; BONE; MIDDLE AGED; NECROSIS; PATHOLOGY;

ADOLESCENT; ADULT; BONE AND BONES; BONE DISEASES; FEMALE; GAUCHER DISEASE; GLUCOSYLCERAMIDASE; HUMANS; MALE; MIDDLE AGED; NECROSIS;

EID: 0030221533     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1006/bcmd.1996.0016     Document Type: Article

References (19)

1. 1. Brady RO, Kanfer JN, Shapiro D. Metabolism of glucocerebrosidases II. Evidence of an enzymatic deficiency in Gaucher's disease. Biochem Biophys Res Comm 18:221-225, 1965.
2. 2. Beutler E, Grabowski GA. Glucosylceramide lipidoses. In: Scriver CR, Beudet AL, Sly WS et al (eds). The Metabolic Basis of Inherited Disease. 7th ed. McGraw-Hill. New York, 1995.
3. 3. Sacks S. Osteitis in Gaucher's disease. Suid-Afrik Tydskrif vir Chir 9:161-166, 1971.
4. 4. Barton NW, Brady RO, Dambrosia JM et al. Replacement therapy for inherited enzyme deficiency: macrophage-targeted gluco-cerebrosidase for Gaucher's disease. N Engl J Med 324:1464-1470, 1991.
5. 5. Fallet S, Grace ME, Sibille A et al. Enzyme augmentation in moderate to life-threatening Gaucher disease. Pediatr Res 31:496-502, 1992.
6. 6. Figueroa ML, Rosenbloom BE, Kay AC et al. A less costly regimen of alglucerase to treat Gaucher's disease. N Engl J Med 327:1632-1636, 1992.
7. 7. Hollak CEM, Aerts JMFG, vanOers MHJ et al. Treatment of Gaucher's disease. N Engl J Med 328:1565-1566, 1992.
8. 8. Zimran A, Elstein D, Kannai R et al. Low-dose enzyme replacement therapy for Gaucher's disease: effects of age, sex, genotype, and clinical features on response to treatment. Am J Med 97:3-13, 1994.
9. 9. Barton NW, Brady RO, Dambrosia JM et al. Dosedependent responses to macrophage-targeted glucocerebrosidase in a child with Gaucher's disease. J Pediatr 120:277-280, 1992.
10. 10. Hill SC, Parker CC, Brady RO. MRI of multiple platyspondyly in Gaucher disease: response to enzyme replacement therapy. J Comput Assist Tomogr 17:806-809, 1993.
11. 11. Beutler E, Demina A, Laubscher K et al. The clinical course of treated and untreated Gaucher disease. A study of 45 patients. Blood Cells Mol Dis 21:86-108, 1995.
12. 12. Zimran A, Sorge J, Gross E. Prediction of severity of Gaucher's disease by identification of mutations at DNA level. Lancet 2:349-353, 1989.
13. 13. Barton NW, Rosenthal DI, Mankin HJ et al. Skeletal responses to enzyme replacement therapy in patients with Gaucher disease: What are the goals and expectations of treatment? Gaucher Clin Persp 4:2-7, 1996.
14. 14. Virtam P, Helela T. Radiographic measure-ments of cortical bone: variations in a normal population between 1 and 90 years of age. Acta Radiol 293(suppl): 7-247, 1969.
15. 15. Rosenthal DI, Doppelt SH, Mankin HJ et al. Enzyme replacement therapy for Gaucher disease: skeletal responses to macrophage-targeted glucocerebrosidase. Pediatrics 96:629-637, 1995.
16. 16. Beutler E, Kuhl W, Vaughan LM. Failure of alglucerase infused into Gaucher disease patients to localize in marrow macrophages. Molec Med 1:320-324, 1995.
17. 17. Mistry PK, Wraight EP, Cox TM. In vivo distribution of mannose-terminated human glucocerebrosidase in patients with Gaucher disease. NIH Technology Assessment Conference, 91-94, 1995.
18. 18. Sidransky E, Ginns EI, Westman JA et al. Pathological fractures may develop in Gaucher patients receiving enzyme replacement therapy. Am J Hemat 47:247-249, 1994.
19. 19. Cohen Y, Elstein D, Abrahamov A et al. hCG contamination of alglucerase: clinical implication in low-dose regimen. Am J Hemat 47:235-236, 1994.